In RA, new use of JAK inhibitors was associated with nonmelanoma skin cancer vs. TNF inhibitors at 2 y - KIVIRID

In RA, new use of JAK inhibitors was associated with nonmelanoma skin cancer vs. TNF inhibitors at 2 y

Authors: Ami Schattner

Published: 2023-07-03

DOI: 10.7326/j23-0042

Source: Full article

Abstract

No abstract found.